Working... Menu
Trial record 27 of 125 for:    lapatinib | Recruiting, Active, not recruiting, Completed Studies | Phase 2

Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02338245
Recruitment Status : Completed
First Posted : January 14, 2015
Last Update Posted : October 17, 2017
Information provided by (Responsible Party):
Aslan Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 19, 2016
  Actual Study Completion Date : August 25, 2016